The y06P protein is a component of Enterobacteria phage T4 (Bacteriophage T4) with the UniProt accession number P39223. This protein plays a role in the phage lifecycle, making it an important target for studying bacteriophage biology and host-phage interactions. Researchers target this protein to investigate phage structural components, replication mechanisms, and potential applications in bacterial detection systems. The commercially available y06P Antibody is a polyclonal antibody raised in rabbits against recombinant Enterobacteria phage T4 y06P protein . This antibody serves as a valuable tool for detecting and studying the presence, distribution, and function of y06P protein in various experimental contexts.
The y06P Antibody (Product Code: CSB-PA336545XA01EDZ) is a polyclonal, non-conjugated IgG antibody raised in rabbits. It is supplied in liquid form and should be stored at -20°C or -80°C to maintain stability and functionality, with repeated freeze-thaw cycles being avoided. The antibody is preserved in a specific buffer composition (0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4) and has undergone antigen affinity purification to ensure specificity . This high level of purification makes it suitable for sensitive applications requiring minimal background interference.
According to the manufacturer's specifications, the y06P Antibody has been validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications . These validation tests confirm the antibody's ability to specifically recognize y06P protein in different experimental formats. While these are the validated applications, experienced researchers may adapt the antibody for use in additional techniques after conducting appropriate validation studies specific to their experimental systems.
Verifying antibody specificity is critical for research integrity. For y06P Antibody, researchers should:
Positive Controls: Include purified recombinant y06P protein at known concentrations.
Negative Controls: Test with lysates from uninfected bacterial cells and/or cells infected with related but distinct bacteriophages.
Peptide Competition Assay: Pre-incubate the antibody with excess purified y06P protein or peptide before testing to confirm signal reduction.
Knockout Validation: If possible, test on phage systems where y06P has been genetically deleted or modified.
Cross-reactivity Assessment: Test against proteins from closely related bacteriophages to assess potential cross-reactivity.
A methodical approach combining multiple validation techniques provides the strongest evidence for antibody specificity, especially important when studying phage proteins that may share sequence homology with other viral or bacterial proteins.
| Control Type | Description | Purpose |
|---|---|---|
| Positive Control | Purified recombinant y06P protein | Confirms antibody functionality |
| Negative Control | Uninfected bacterial lysate | Ensures specificity for phage protein |
| Loading Control | Host bacterial protein (e.g., 16S rRNA) | Normalizes sample loading |
| Secondary Antibody Control | Secondary antibody only (no primary) | Detects non-specific binding |
| Pre-absorption Control | Antibody pre-incubated with target | Confirms signal specificity |
| Molecular Weight Marker | Standard protein ladder | Confirms target protein size |
The inclusion of these controls allows researchers to confidently interpret Western blot results by distinguishing specific signals from technical artifacts. For time-course studies of phage infection, samples collected at different infection timepoints serve as internal controls that demonstrate the dynamics of y06P expression .
ELISA optimization with y06P Antibody requires systematic parameter adjustment:
Antibody Titration: Test serial dilutions (typically 1:500 to 1:10,000) to determine optimal concentration that maximizes signal-to-noise ratio.
Blocking Agent Selection: Compare different blocking agents (BSA, milk proteins, commercial blockers) to minimize background while preserving specific binding.
Sample Preparation: Optimize lysis conditions to ensure complete protein extraction while preserving epitope integrity.
Incubation Parameters: Test various antibody incubation temperatures (4°C, room temperature) and durations (1 hour to overnight) to enhance binding efficiency.
Detection System: Compare direct vs. indirect detection methods and various substrates to maximize sensitivity.
An optimized ELISA protocol typically achieves detection limits in the nanogram range for phage proteins, with standard curves showing linearity (R² > 0.98) across at least two orders of magnitude of target concentration.
For studying bacteriophage assembly kinetics, researchers can implement time-course experiments with the following methodology:
Synchronous Infection: Infect bacterial cultures with T4 phage at high multiplicity of infection (MOI >5) to ensure synchronized infection.
Timed Sample Collection: Collect samples at defined intervals post-infection (e.g., 5, 10, 15, 20, 30, 45, 60 minutes).
Subcellular Fractionation: Separate bacterial lysates into membrane, cytosolic, and phage particle fractions.
Quantitative Western Blot: Use y06P Antibody to detect and quantify protein levels in different fractions over time.
Correlation Analysis: Compare y06P protein appearance with other phage structural proteins and with the appearance of complete phage particles.
This approach enables researchers to construct detailed models of phage assembly processes, identifying rate-limiting steps and assembly checkpoints. The data can be presented as line graphs showing y06P protein levels across different subcellular fractions over time, with correlation coefficients calculated between y06P appearance and infectious particle formation.
Quantitative analysis of y06P expression requires techniques that provide accurate protein measurements:
Quantitative Western Blotting:
Use purified recombinant y06P protein to generate standard curves
Implement digital image analysis software for densitometry
Include multiple technical and biological replicates
Quantitative ELISA:
Develop sandwich ELISA using y06P Antibody as capture or detection antibody
Generate standard curves with recombinant protein
Calculate concentrations using four-parameter logistic regression
Mass Spectrometry-based Quantification:
Implement Selected Reaction Monitoring (SRM) or Multiple Reaction Monitoring (MRM)
Use isotope-labeled peptide standards for absolute quantification
Combine with immunoprecipitation using y06P Antibody for enrichment
These methods can detect y06P protein expression across a dynamic range of at least 3 orders of magnitude, allowing researchers to precisely track protein accumulation during infection cycles and correlate expression levels with phage production efficiency.
Investigating y06P's role in phage-host interactions requires multilayered experimental approaches:
Co-immunoprecipitation with y06P Antibody:
Identify host proteins that interact with y06P during infection
Confirm interactions with reciprocal pull-downs
Validate with techniques like proximity ligation assay
Localization Studies:
Perform immunofluorescence microscopy using y06P Antibody
Combine with fluorescently labeled host proteins
Track temporal and spatial distribution during infection cycle
Functional Interference:
Use y06P Antibody to block protein function in permeabilized cells
Compare phage production with and without antibody treatment
Measure effects on specific stages of phage replication
Structural Biology Integration:
Combine with cryo-electron microscopy data
Map y06P localization to phage structural components
Correlate with host membrane interaction sites
These approaches can reveal whether y06P serves primarily structural roles or participates in host defense evasion, resource acquisition, or other aspects of phage-host biology.
| Issue | Potential Causes | Solutions |
|---|---|---|
| No signal in Western blot | - Protein denaturation affecting epitope - Insufficient protein transfer - Excessive blocking - Antibody degradation | - Try native conditions - Verify transfer with reversible stain - Reduce blocking time/concentration - Use fresh antibody aliquot |
| No signal in ELISA | - Coating buffer incompatibility - Inadequate antigen concentration - Epitope masking - Instrument sensitivity issues | - Test multiple coating buffers - Increase antigen concentration - Try different sample preparation methods - Use more sensitive detection system |
| Signal below detection threshold | - Low y06P expression - Inefficient protein extraction - Sample degradation - Suboptimal antibody concentration | - Concentrate samples - Optimize lysis protocol with protease inhibitors - Process samples rapidly at 4°C - Increase antibody concentration |
| Inconsistent results | - Variable infection efficiency - Lot-to-lot antibody variation - Temperature fluctuations - Protocol inconsistencies | - Standardize MOI and infection protocols - Test new antibody lots against standards - Maintain consistent temperature - Use detailed SOPs |
Methodical troubleshooting following this framework can resolve most detection issues, with documentation of optimization steps creating valuable reference data for future experiments.
Optimal antibody dilution determination requires systematic titration experiments:
Western Blot Optimization:
Test dilution series from 1:500 to 1:5000
Use consistent protein amounts across lanes
Quantify signal-to-noise ratio for each dilution
Select dilution with highest specific signal and lowest background
ELISA Optimization:
Perform checkerboard titration with antigen (columns) vs. antibody (rows)
Calculate signal-to-noise ratio for each combination
Determine optimal working range
Verify with standard curves
Immunofluorescence Optimization (if applicable):
Test dilutions from 1:100 to 1:1000
Include autofluorescence and secondary-only controls
Measure signal intensity and background for each condition
Select dilution maximizing contrast between specific and background signal
For each application, the optimal dilution should produce consistent results across at least three independent experiments, with coefficient of variation < 15% for quantitative measurements.
When studying low-abundance y06P expression, standard protocols can be enhanced through:
Signal Amplification Strategies:
Implement tyramide signal amplification (TSA) for immunoassays
Use high-sensitivity chemiluminescent substrates for Western blots
Apply biotin-streptavidin amplification systems
Sample Enrichment Techniques:
Perform immunoprecipitation before analysis
Use subcellular fractionation to concentrate target
Implement density gradient separation of phage components
Detection System Enhancements:
Utilize cooled CCD cameras for chemiluminescence detection
Employ photomultiplier tube-based plate readers for ELISA
Consider digital droplet PCR coupled with proximity ligation assay
Protocol Modifications:
Extend primary antibody incubation (overnight at 4°C)
Reduce washing stringency while maintaining specificity
Use signal enhancers compatible with detection system
These enhancements can improve detection limits by 5-10 fold compared to standard protocols, enabling analysis of y06P in experimental systems with limited expression or in early infection stages.
When evaluating antibody performance across different bacteriophage protein targets:
| Antibody Target | Specificity | Sensitivity | Cross-reactivity | Applications | Production Method |
|---|---|---|---|---|---|
| y06P (T4) | High (single band) | 10-50 ng range | Minimal with related phages | ELISA, WB | Polyclonal (rabbit) |
| gp23 (T4 major capsid) | Very high | 5-20 ng range | Some with T-even phages | ELISA, WB, IF, EM | Monoclonal and polyclonal |
| gp5 (T4 baseplate) | Moderate-high | 20-100 ng range | Some with related phages | ELISA, WB | Polyclonal |
| λ capsid protein E | High | 10-25 ng range | Minimal | ELISA, WB, IF | Monoclonal |
| M13 pVIII | Very high | 1-10 ng range | Minimal | ELISA, WB, IF, EM | Monoclonal and polyclonal |
This comparative analysis shows that while y06P Antibody demonstrates strong specificity and adequate sensitivity, some antibodies against major structural proteins offer higher sensitivity or broader application ranges. For most research applications targeting y06P specifically, the current antibody provides sufficient performance metrics .
Multiplexed detection strategies enable simultaneous analysis of multiple phage proteins:
Multiplex Western Blotting:
Strip and reprobe membranes with antibodies against different targets
Use antibodies raised in different host species
Employ fluorescently labeled secondary antibodies with distinct spectra
Analyze with multi-channel imaging systems
Sandwich ELISA Approaches:
Develop multi-well ELISA with different capture antibodies
Use biotinylated detection antibodies with avidin-enzyme conjugates
Implement spectral discrimination with different substrates
Immunofluorescence Multiplexing:
Apply primary antibodies sequentially with blocking steps
Use secondary antibodies with non-overlapping emission spectra
Employ confocal microscopy with spectral unmixing
Bead-Based Multiplex Assays:
Conjugate antibodies to spectrally distinct beads
Analyze by flow cytometry or dedicated multiplex readers
Provide simultaneous quantification of multiple targets
These approaches enable researchers to study the temporal and spatial relationships between y06P and other phage proteins during infection, assembly, and host interaction processes.
The y06P Antibody can be leveraged for evolutionary studies through:
Cross-reactivity Testing:
Screen environmental phage isolates for y06P homologs
Quantify binding affinity across related phages
Map conservation and divergence of epitopes
Structural Comparisons:
Combine with structural biology techniques
Identify conserved functional domains
Map evolutionary relationships between phage lineages
Metagenomic Integration:
Correlate antibody binding with genomic sequence data
Develop antibody-based enrichment for targeted metagenomics
Track y06P variants in environmental samples
Functional Conservation Analysis:
Compare y06P localization across phage families
Assess functional complementation between homologs
Determine evolutionary pressure on different protein regions
These approaches can reveal how y06P has evolved across bacteriophage lineages, potentially uncovering functional constraints and adaptation mechanisms that could inform both basic phage biology and biotechnological applications.
Emerging technologies poised to revolutionize antibody applications include:
Nanobody and Single-Domain Antibody Derivatives:
Develop smaller, more stable binding molecules
Enhance penetration into complex structures
Improve accessibility to cryptic epitopes
Proximity-Based Labeling:
Conjugate peroxidase or biotin ligase to y06P Antibody
Identify neighboring proteins in phage-host complexes
Map temporal interactions during infection
Super-Resolution Microscopy Integration:
Combine with STORM, PALM, or STED techniques
Achieve nanometer-scale localization of y06P
Visualize assembly intermediates with unprecedented detail
Antibody-Based Biosensors:
Develop phage detection platforms
Create real-time monitoring systems for infection dynamics
Engineer feedback-responsive experimental systems
Cryo-Electron Tomography Applications:
Use antibody-gold conjugates as fiducial markers
Identify y06P localization in intact phage particles
Resolve structural transitions during host interaction
These technological advances promise to extend the utility of y06P Antibody beyond current applications, potentially enabling real-time tracking, enhanced structural studies, and more sensitive detection methodologies.